Mechanisms of Quinolone Resistance

作者: David C. Hooper

DOI: 10.1128/9781555816513.CH65

关键词:

摘要: With the increasing use of quinolones for treatment gram-positive bacterial infections, an understanding mechanisms quinolone resistance in bacteria is considerable importance. This chapter summarizes current established to this class antimicrobial agents bacteria. There are important differences between and gram negative both target enzyme sensitivity means by which efflux operate that clinical fundamental Quinolones interact with two type 2 topoisomerases eubacteria, DNA gyrase topoisomerase IV, essential replication. Quinolone-resistant laboratory strains Streptococcus pneumoniae have been shown reduced accumulation reversible reserpine, suggesting involvement system(s) resistance. isolates viridans streptococci phenotype defined as lower MICs presence reserpine. from such S. mitis oralis was able transform laboratory. Overexpression norA genes plasmids known, however, toxic effects on cell may limit fitness resistant containing them. Thus, at present attributable exclusively chromosomal mutations affect targets or permeation these targets.

参考文章(279)
D C Hooper, J S Wolfson, K S Souza, E Y Ng, G L McHugh, M N Swartz, Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrobial Agents and Chemotherapy. ,vol. 33, pp. 283- 290 ,(1989) , 10.1128/AAC.33.3.283
N Masuda, S Ohya, Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. ,vol. 36, pp. 1847- 1851 ,(1992) , 10.1128/AAC.36.9.1847
James M. Berger, Steven J. Gamblin, Stephen C. Harrison, James C. Wang, Structure and mechanism of DNA topoisomerase II Nature. ,vol. 379, pp. 225- 232 ,(1996) , 10.1038/379225A0
P.-C. Hsieh, S. A. Siegel, B. Rogers, D. Davis, K. Lewis, Bacteria lacking a multidrug pump: A sensitive tool for drug discovery Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 6602- 6606 ,(1998) , 10.1073/PNAS.95.12.6602
Bénédicte Fournier, Xilin Zhao, Tao Lu, Karl Drlica, David C. Hooper, Selective Targeting of Topoisomerase IV and DNA Gyrase in Staphylococcus aureus: Different Patterns of Quinolone- Induced Inhibition of DNA Synthesis Antimicrobial Agents and Chemotherapy. ,vol. 44, pp. 2160- 2165 ,(2000) , 10.1128/AAC.44.8.2160-2165.2000
X Z Li, D M Livermore, H Nikaido, Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 1732- 1741 ,(1994) , 10.1128/AAC.38.8.1732
E. C. Pesci, J. B. J. Milbank, J. P. Pearson, S. McKnight, A. S. Kende, E. P. Greenberg, B. H. Iglewski, Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 11229- 11234 ,(1999) , 10.1073/PNAS.96.20.11229
Michelle Sabourin, Jo Ann Wilson Byl, S. Erin Hannah, John L. Nitiss, Neil Osheroff, A Mutant Yeast Topoisomerase II (top2G437S) with Differential Sensitivity to Anticancer Drugs in the Presence and Absence of ATP Journal of Biological Chemistry. ,vol. 273, pp. 29086- 29092 ,(1998) , 10.1074/JBC.273.44.29086
Y Wang, W M Huang, D E Taylor, Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrobial Agents and Chemotherapy. ,vol. 37, pp. 457- 463 ,(1993) , 10.1128/AAC.37.3.457